Invention Grant
- Patent Title: Therapeutic agent for fatty liver disease
-
Application No.: US18171126Application Date: 2023-02-17
-
Publication No.: US12023320B2Publication Date: 2024-07-02
- Inventor: Ayatoshi Ando , Ippei Kawanishi , Seiji Shiraishi , Harumi Tanaka , Yuki Saitou
- Applicant: EA PHARMA CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: EA PHARMA CO., LTD.
- Current Assignee: EA PHARMA CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP 20138703 2020.08.19
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61P1/16
Abstract:
An object of the present invention is to provide a therapeutic agent for fatty liver diseases. The above object can be achieved by a therapeutic agent for a fatty liver disease, comprising a compound represented by the following formula (1):
or a pharmaceutically acceptable salt thereof.
or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20230201163A1 THERAPEUTIC AGENT FOR FATTY LIVER DISEASE Public/Granted day:2023-06-29
Information query
